Zhiqin Bu

ORCID: 0000-0003-2343-3493 · 10 papers in corpus
2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1416841

PurposeTo investigate potential differences in pregnancy outcomes among patients with regular menstruation who underwent frozen-thawed embryo transfer using natural cycle (NC) or hormone replacement therapy (HRT).MethodsThis study retrospec…

2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00841-x

BackgroundTo investigate whether the endometrial thickness change ratio from the progesterone administration day to the blastocyst transfer day is associated with pregnancy outcomes in a single frozen-thawed euploid blastocyst transfer cycl…

article 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.655803

Background Some studies have demonstrated that adenomyosis patients can achieve a comparable pregnancy outcome with women with normal uteruses, while there is no unanimous conclusion at present. Method We recruited 65 adenomyosis patients a…

2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.727339

BackgroundCurrently, in China, only women undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles can donate oocytes to others, but at least 15 oocytes must be kept for their own treatment. Thus, the aim of this…

article 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00469

Background: Studies have shown that patients with a thin endometrial thickness (EMT 5). In binary logistic regression analysis, age (OR=0.09, P=0.03), number of embryos available(OR=1.71, P=0.00), and uterine condition (OR=6.77, P=0.00 for …

other 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2019.11.001

RESEARCH QUESTION: Which factors are related to early spontaneous miscarriage in IVF-conceived clinical pregnancies? DESIGN: A total of 21,485 clinical pregnancies were included in the analysis. First, early spontaneous miscarriage rates w…

other 2019
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/MSM.916447

BACKGROUND Patients with endometriosis (EMs) are routinely advised to take GnRH-a for 3-6 months to improve the internal reproductive environment, but this may not be necessary. MATERIAL AND METHODS This retrospective study examined the eff…

article 2019
·doi:10.12659/msm.916447

BACKGROUND: Patients with endometriosis (EMs) are routinely advised to take GnRH-a for 3–6 months to improve the internal reproductive environment, but this may not be necessary. MATERIAL/METHODS: This retrospective study examined the effec…

rct 2018
Reproductive health ·doi:10.1186/s12978-018-0639-8

BACKGROUND: Endometriosis is the major cause of progressive pelvic pain and subfertility. Up to 50% of reproductive-age women suffer from pelvic pain. Endometriosis is a classic indication for IVF. Compared with women whose inability to pro…

2014
PloS one ·doi:10.1371/journal.pone.0100011

In order to explore the relationship between serum progesterone (P) level on the day of human chorionic gonadotrophin (HCG) administration and cumulative live birth rate in patients with different ovarian response during in vitro fertilizat…